0 TSX News - March 3, 2020Trevali Announces Management ChangeVANCOUVER, British Columbia, March 03, 2020 (GLOBE NEWSWIRE) — Trevali Mining Corporation (“Trevali” or the “Company”) (TSX: TV, BVL: TV; […]Read More
0 NASDAQ Companies - March 3, 2020Applied Optoelectronics Announces Withdrawal from OFC 2020SUGAR LAND, Texas, March 03, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (Nasdaq: AAOI), a leading provider of fiber-optic access […]Read More
0 NASDAQ Companies - March 3, 2020Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress– Conference call to be held on March 3, 2020 at 8:30 am EST/1:30 pm GMT –LONDON, March 03, 2020 […]Read More
0 NASDAQ Companies - March 3, 2020Venus Concept Expands Executive TeamTORONTO, March 03, 2020 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical […]Read More
0 NASDAQ Companies - March 3, 2020The Joint Corp. Secures $7.5 Million Line of Credit with J.P. Morgan Chase BankSCOTTSDALE, Ariz., March 03, 2020 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of […]Read More
0 NASDAQ Companies - March 3, 2020Qorvo Announces Revised Guidance for Fiscal 2020 Fourth QuarterGREENSBORO, N.C., March 03, 2020 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect […]Read More
0 NASDAQ Companies - March 3, 2020TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial ResultsNEW YORK, March 03, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the […]Read More
0 NASDAQ Companies - March 3, 2020Pluristem Receives Response from U.S. BARDA for Acute Radiation Syndrome Research ProposalHAIFA, Israel, March 03, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]Read More
0 NASDAQ Companies - March 3, 2020Immuron Provides Update on First Half of FY20 ResultsKey Highlights:Strong continued growth of Travelan® sales reported in all marketsGlobal sales reached USD $1.1 million (AUD $1.68 million) for […]Read More
0 NASDAQ Companies - March 3, 2020uniQure to Participate in Multiple Upcoming Industry Conferences in MarchLEXINGTON, Mass. and AMSTERDAM, March 03, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]Read More